People with lupus-related skin problems are more likely to develop heart disease associated with hardening of the a ...

Houston Methodist researchers have identified a key protein as a potential therapeutic target for stopping the body's immune ...

Hyderabad: IIIT Hyderabad, in collaboration with Nizam's Institute of Medical Sciences (NIMS), has released digitised ...

On Tuesday, the U.S. Food and Drug Administration (FDA) placed a clinical hold on Atara Biotherapeutics, Inc.’s (NASDAQ:ATRA) ...

Lupus is a chronic disease that can cause inflammation and pain in any part of the body. It’s an autoimmune disease, which ...

ImmuPharma plc (LON:IMM – Get Free Report) rose 27.6% on Saturday . The company traded as high as GBX 3.60 ($0.04) and last ...

Cutaneous lupus erythematosus (CLE) is associated with an increased risk for atherosclerotic cardiovascular disease ...

Atara Biotherapeutics said the U.S. Food and Drug Administration placed a clinical hold on its active investigational new drug applications. The biotechnology company said the FDA put a hold on its ...

Dr Sudhir Karmacharya, a lupus specialist at the National Center for Rheumatic Diseases (NECRD), stated that lupus is more ...

After receiving a complete response letter last week, the other shoe has dropped for Atara Biotherapeutics and its pipeline ...